Overview Financials News + Filings IR Vault Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Notes underwriting agrmnt
Inv. presentation
Asset disposition
Appointed CFO
Quarterly results
Director departure
Appointed director
|
|
ARCA biopharma, Inc. (ABIO)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 02/08/2023 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/10/2021 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/10/2021 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 01/06/2021 |
SC 13G/A
| SABBY MANAGEMENT, LLC reports a 0% stake in ARCA BIOPHARMA, INC. |
| 02/12/2020 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 01/24/2020 |
SC 13G/A
| Tekla Capital Management LLC reports a 2.3% stake in ARCA biopharma, Inc. |
| 02/12/2019 |
SC 13G/A
| Tekla Capital Management LLC reports a 5.8% stake in ARCA biopharma, Inc. |
| 03/08/2018 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/12/2018 |
SC 13G/A
| Tekla Capital Management LLC reports a 6.9% stake in ARCA biopharma, Inc. |
| 02/05/2018 |
SC 13G/A
| FRANKLIN RESOURCES INC reports a 13.9% stake in ARCA BIOPHARMA, INC. |
| 01/04/2018 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/14/2017 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/14/2017 |
SC 13G/A
| ARCA biopharma, Inc. reports a 5.9% stake in ARCA biopharma, Inc. |
| 02/13/2017 |
SC 13G/A
| Tekla Capital Management LLC reports a 811227% stake in ARCA biopharma, Inc. |
| 02/16/2016 |
SC 13G/A
| VENROCK HEALTHCARE CAPITAL PARTNERS LP reports a 19.9% stake in ARCA biopharma, Inc. |
| 02/11/2013 |
SC 13G/A
| Atlas Venture Fund VII L P reports a 12.3% stake in ARCA BIOPHARMA, INC. |
| 02/14/2012 |
SC 13G/A
| Iroquois Capital Management, LLC reports a 4.9% stake in ARCA biopharma, Inc. |
| 02/14/2012 |
SC 13G/A
| InterWest Partners IX, LP reports a 0.2% stake in ARCA BIOPHARMA, INC. |
| 02/13/2012 |
SC 13G/A
| ARCA biopharma, Inc. reports a 4.9% stake in ARCA biopharma, Inc. |
| 02/10/2012 |
SC 13G/A
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals [amend] |
| 02/10/2011 |
SC 13G/A
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals [amend] |
| 02/10/2011 |
SC 13G/A
| ARCA biopharma, Inc. reports a 15% stake in ARCA BIOPHARMA, INC. |
| 02/04/2011 |
SC 13G/A
| ARCA biopharma, Inc. has filed a Schedule 13D for ARCA BIOPHARMA, INC. |
| 02/12/2010 |
SC 13G/A
| ARCA biopharma, Inc. reports a 0% stake in ARCA BIOPHARMA, INC. |
| 02/12/2010 |
SC 13G/A
| ARCA biopharma, Inc. reports a 1.6% stake in ARCA BIOPHARMA, INC. |
| 02/05/2010 |
SC 13G/A
| Atlas Venture Fund VII L P reports a 19.2% stake in ARCA BIOPHARMA, INC. |
| 02/17/2009 |
SC 13G/A
| Form SC 13G/A -- Statement of acquisition of beneficial ownership by individuals [amend] |
|
|